Equal opportunity CAR T cells

Rayne H. Rouce, Helen Heslop

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


In this issue of Blood, Gardner et al report results of a phase 1 trial of 45 children and young adults with relapsed or refractory B-lineage acute lymphoblastic leukemia (ALL) who received a T-cell product of defined CD4/CD8 composition that was genetically modified with a CD19-4-1BB: z chimeric antigen receptor (CAR) lentiviral vector.

Original languageEnglish (US)
Pages (from-to)3275-3277
Number of pages3
Issue number25
StatePublished - Jun 22 2017

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Equal opportunity CAR T cells'. Together they form a unique fingerprint.

Cite this